Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-21

FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TROKENDI XR (topiramate) from Supernus Pharmaceuticals, authorizing an update to the product via a supplemental appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TROKENDI XR (TOPIRAMATE)

Snippet

SUPPL AP for TROKENDI XR (TOPIRAMATE)